ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Clinical trial NCT05059444 · RECRUITING

Trial details

NCT number: NCT05059444
Sponsor: Guardant Health, Inc.
Status: RECRUITING
Study type: OBSERVATIONAL

Bladder Carcinoma Ureter Carcinoma Renal Pelvis Carcinoma Non-small Cell Lung Cancer Invasive Breast Carcinoma Cutaneous Melanoma Esophageal Carcinoma Gastroesophageal Junction Carcinoma Gastric Adenocarcinoma Pancreatic Adenocarcinoma Squamous Cell Carcinoma of the Head and Neck Epithelial Ovarian Carcinoma

Start date: 2021-09-07
Primary completion: 2029-08-01
Enrollment: 2020

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.